CTSO Cytosorbents Corp Forecast, Technical & Fundamental Analysis
CytoSorbents Corp is a leader in blood purification for the treatment of life-threatening conditions in the intensive care unit and cardiac surgery... Show more
CTSO is expected to report earnings to fall 17.40% to -4 cents per share on August 04
Q2'26
Est.
$-0.04
Q1'26
Missed
by $0.01
Q4'25
Missed
by $0.03
Q3'25
Beat
by $0.01
Q2'25
Missed
by $0.01
The last earnings report on May 13 showed earnings per share of -5 cents, missing the estimate of -3 cents. With 78.33K shares outstanding, the current market capitalization sits at 24.23M.
A.I. Advisor
published General Information
General Information
a developer of products to support healthcare professionals in the treatment of complex medical conditions
A.I.dvisor tells us that CTSO and TELA have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CTSO and TELA's prices will move in lockstep.
Momentum Indicator for CTSO turns negative, indicating new downward trend
CTSO saw its Momentum Indicator move below the 0 level on June 26, 2026. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 102 similar instances where the indicator turned negative. In of the 102 cases, the stock moved further down in the following days. The odds of a decline are at .
Technical Analysis (Indicators)
Bearish Trend Analysis
Following a 3-day decline, the stock is projected to fall further. Considering past instances where CTSO declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
The Aroon Indicator for CTSO entered a downward trend on June 18, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Bullish Trend Analysis
The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where CTSO's RSI Oscillator exited the oversold zone, of 34 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .
The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 1 day, which means it's wise to expect a price bounce in the near future.
The Moving Average Convergence Divergence (MACD) for CTSO just turned positive on July 06, 2026. Looking at past instances where CTSO's MACD turned positive, the stock continued to rise in of 50 cases over the following month. The odds of a continued upward trend are .
Following a +1 3-day Advance, the price is estimated to grow further. Considering data from situations where CTSO advanced for three days, in of 242 cases, the price rose further within the following month. The odds of a continued upward trend are .
CTSO may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Fundamental Analysis (Ratings)
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (11.050) is normal, around the industry mean (11.304). P/E Ratio (0.000) is within average values for comparable stocks, (65.575). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (3.940). CTSO has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.017). P/S Ratio (0.650) is also within normal values, averaging (25.693).
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. CTSO’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CTSO’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.
